This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of James P. Hardwick
Introduction
James P. Hardwick is an accomplished inventor based in Argonne, Illinois. He has made significant contributions to the field of pharmacogenetics, particularly in identifying genetic defects that affect drug metabolism. His work has implications for personalized medicine and drug testing.
Latest Patents
James P. Hardwick holds a patent for "P450db1 clones for identifying humans with genetic defect in drug." This patent involves a cloned cDNA encoding the debrisoquine 4-hydroxylase gene and a probe designed to identify individuals with a genetic defect in the metabolism of certain drugs, using debrisoquine as a model. The patent also describes a simple assay for testing new drugs and human subjects.
Career Highlights
Hardwick is associated with the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding of how genetic variations can influence drug efficacy and safety.
Collaborations
Some of his notable coworkers include Frank J. Gonzalez and Harry V. Gelboin. Their collaborative efforts have contributed to the advancements in the field of drug metabolism and genetic research.
Conclusion
James P. Hardwick's innovative work in pharmacogenetics has paved the way for improved drug testing and personalized medicine. His contributions continue to impact the medical field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile